Work

Prognostic value of Day 14 measurable residual disease in acute myeloid leukemia treated with venetoclax and azacitidine

Year: 2025

Type: article

Study design: Observational Study

Source: Cancer

DOI: 10.1002/cncr.70053

Authors: Jiaying Lian, Xianxu Zhuang, Ying Chen, Qingqing Lin, Renzhi Pei, Dong Chen, Shuangyue Li, Peipei Ye, Junjie Cao, Jiaojiao Yuan, Xiaowei Shi, Xuhui Liu, Ying Lu

Institution: Ningbo University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4413699731

FWCI: 0.654

Cites: 20

Cited by: 1

Related to: 10